The pharmacokinetics of proguanil in human subjects following a single oral dose. 1987

E M Chiluba, and K A Fletcher, and A H Price

The pharmacokinetics of orally administered 200-mg dose of proguanil in volunteers, one African and one Caucasian, is described. The drug was rapidly absorbed reaching a peak concentration in the blood within 3 h, and declining slowly thereafter to give a terminal phase elimination half life of 11.20 +/- 4.10 h and a systemic clearance of 1.270 +/- 0.020 l/h/kg. The small apparent volume of distribution shows that the drug is confined mainly to the blood and is not extensively bound to tissues; it undergoes cyclic oxidation in the liver to cycloguanil--the active metabolite responsible for antimalarial activity. Cycloguanil was detected in the plasma 3 h after proguanil ingestion and reached peak concentration between 5 h and 6 h. Excretion of proguanil was rapid, 60% of the single dose passing through the renal system within 24 h.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D002727 Proguanil A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent. Chlorguanid,Chloroguanide,Bigumal,Chloriguane,Chloroguanide Hydrochloride,Paludrin,Paludrine,Proguanil Hydrochloride,Hydrochloride, Chloroguanide,Hydrochloride, Proguanil
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines

Related Publications

E M Chiluba, and K A Fletcher, and A H Price
December 1987, British journal of clinical pharmacology,
E M Chiluba, and K A Fletcher, and A H Price
August 1978, Journal of pharmacokinetics and biopharmaceutics,
E M Chiluba, and K A Fletcher, and A H Price
January 1987, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
E M Chiluba, and K A Fletcher, and A H Price
September 1985, Journal of pharmaceutical sciences,
E M Chiluba, and K A Fletcher, and A H Price
January 1982, Journal of clinical pharmacology,
E M Chiluba, and K A Fletcher, and A H Price
August 2020, Cancer chemotherapy and pharmacology,
E M Chiluba, and K A Fletcher, and A H Price
March 1993, Biopharmaceutics & drug disposition,
E M Chiluba, and K A Fletcher, and A H Price
October 1977, Journal of pharmacokinetics and biopharmaceutics,
E M Chiluba, and K A Fletcher, and A H Price
January 1993, European journal of clinical pharmacology,
E M Chiluba, and K A Fletcher, and A H Price
January 1991, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!